{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:47:11Z","timestamp":1791089231064,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS104403"],"award-info":[{"award-number":["R01NS104403"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background\/Purpose<\/jats:title>\n                    <jats:p>Leptomeningeal enhancement (LME) on post-contrast FLAIR is described as a potential biomarker of meningeal inflammation in multiple sclerosis (MS). Here we report an assessment of the impact of MRI field strength and acquisition timing on meningeal contrast enhancement (MCE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional, observational study of 95 participants with MS and 17 healthy controls (HC) subjects. Each participant underwent an MRI of the brain on both a 7 Tesla (7T) and 3 Tesla (3T) MRI scanner. 7T protocols included a FLAIR image before, soon after (Gd+ Early 7T FLAIR), and 23 minutes after gadolinium (Gd+ Delayed 7T FLAIR). 3T protocol included FLAIR before and 21 minutes after gadolinium (Gd+ Delayed 3T FLAIR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LME was seen in 23.3% of participants with MS on Gd+ Delayed 3T FLAIR, 47.4% on Gd+ Early 7T FLAIR (p = 0.002) and 57.9% on Gd+ Delayed 7T FLAIR (p &lt; 0.001 and p = 0.008, respectively). The count and volume of LME, leptomeningeal and paravascular enhancement (LMPE), and paravascular and dural enhancement (PDE) were all highest for Gd+ Delayed 7T FLAIR and lowest for Gd+ Delayed 3T FLAIR. Non-significant trends were seen for higher proportion, counts, and volumes for LME and PDE in MS compared to HCs. The rate of LMPE was different between MS and HCs on Gd+ Delayed 7T FLAIR (98.9% vs 82.4%, p = 0.003). MS participants with LME on Gd+ Delayed 7T FLAIR were older (47.6 (10.6) years) than those without (42.0 (9.7), p = 0.008).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>7T MRI and a delay after contrast injection increased sensitivity for all forms of MCE. However, the lack of difference between groups for LME and its association with age calls into question its relevance as a biomarker of meningeal inflammation in MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0300298","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T13:35:29Z","timestamp":1716989729000},"page":"e0300298","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8707-2004","authenticated-orcid":true,"given":"Daniel M.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohance M.","family":"Allette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongjin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"issue":"Pt 9","key":"pone.0300298.ref001","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"OW Howell","year":"2011","journal-title":"Brain"},{"issue":"4","key":"pone.0300298.ref002","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"R Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"key":"pone.0300298.ref003","article-title":"Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study","author":"M Vercellino","year":"2023","journal-title":"Mult Scler"},{"issue":"Pt 4","key":"pone.0300298.ref004","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"R Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"8","key":"pone.0300298.ref005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.0000000000001286","article-title":"Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study","volume":"84","author":"P Eisele","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"pone.0300298.ref006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"M Absinta","year":"2015","journal-title":"Neurology"},{"key":"pone.0300298.ref007","doi-asserted-by":"crossref","first-page":"8652463","DOI":"10.1155\/2017\/8652463","article-title":"Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis","volume":"2017","author":"G Makshakov","year":"2017","journal-title":"Neurol Res Int"},{"key":"pone.0300298.ref008","article-title":"Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study","author":"R Zivadinov","year":"2016","journal-title":"Mult Scler"},{"key":"pone.0300298.ref009","doi-asserted-by":"crossref","first-page":"102456","DOI":"10.1016\/j.nicl.2020.102456","article-title":"CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review","volume":"28","author":"WM Freeze","year":"2020","journal-title":"Neuroimage Clin"},{"key":"pone.0300298.ref010","article-title":"No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis","author":"M Ighani","year":"2019","journal-title":"Mult Scler"},{"issue":"3","key":"pone.0300298.ref011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/13524585211023343","article-title":"Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI","volume":"28","author":"R Mizell","year":"2022","journal-title":"Mult Scler"},{"issue":"2","key":"pone.0300298.ref012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1352458519885106","article-title":"7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions","volume":"26","author":"J Zurawski","year":"2020","journal-title":"Mult Scler"},{"key":"pone.0300298.ref013","article-title":"Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume","author":"DM Harrison","year":"2017","journal-title":"J Neuroimaging"},{"issue":"10","key":"pone.0300298.ref014","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3174\/ajnr.A5796","article-title":"Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis","volume":"39","author":"SN Jonas","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"pone.0300298.ref015","doi-asserted-by":"crossref","first-page":"102653","DOI":"10.1016\/j.msard.2020.102653","article-title":"Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis","volume":"47","author":"FE Hildesheim","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"pone.0300298.ref016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2016.4237","article-title":"Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review","volume":"74","author":"J Zurawski","year":"2017","journal-title":"JAMA Neurol"},{"issue":"2","key":"pone.0300298.ref017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"AJ Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"pone.0300298.ref018","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0730-725X(94)92355-8","article-title":"Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods","volume":"12","author":"PS Tofts","year":"1994","journal-title":"Magn Reson Imaging"},{"key":"pone.0300298.ref019","doi-asserted-by":"crossref","first-page":"105344","DOI":"10.1016\/j.msard.2023.105344","article-title":"A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis","volume":"81","author":"S Dahal","year":"2023","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"pone.0300298.ref020","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuroimage.2009.10.002","article-title":"MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field","volume":"49","author":"JP Marques","year":"2010","journal-title":"Neuroimage"},{"issue":"6","key":"pone.0300298.ref021","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: improved N3 bias correction","volume":"29","author":"NJ Tustison","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"2","key":"pone.0300298.ref022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-015-0273-8","article-title":"Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases","volume":"36","author":"EN Bakker","year":"2016","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"pone.0300298.ref023","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.20199","article-title":"Early blood-brain barrier disruption in human focal brain ischemia","volume":"56","author":"LL Latour","year":"2004","journal-title":"Ann Neurol"},{"issue":"11","key":"pone.0300298.ref024","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.STR.0000144051.32131.09","article-title":"Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption","volume":"35","author":"S Warach","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"pone.0300298.ref025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ana.25928","article-title":"Noninvasive Characterization of Human Glymphatics and Meningeal Lymphatics in an in vivo Model of Blood-Brain Barrier Leakage","volume":"89","author":"CH Wu","year":"2021","journal-title":"Ann Neurol"},{"issue":"2","key":"pone.0300298.ref026","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1148\/radiology.210.2.r99ja22551","article-title":"Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging","volume":"210","author":"M Essig","year":"1999","journal-title":"Radiology"},{"issue":"918","key":"pone.0300298.ref027","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1259\/bjr\/51430802","article-title":"Case report: delayed post-contrast fluid-attenuated inversion recovery image for depicting meningeal carcinomatosis","volume":"77","author":"T Hirota","year":"2004","journal-title":"Br J Radiol"},{"issue":"6","key":"pone.0300298.ref028","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jon.12774","article-title":"Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice","volume":"30","author":"DS Titelbaum","year":"2020","journal-title":"J Neuroimaging"},{"key":"pone.0300298.ref029","doi-asserted-by":"crossref","first-page":"102939","DOI":"10.1016\/j.nicl.2022.102939","article-title":"Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: A systematic review and Meta-Analysis","volume":"33","author":"BV Ineichen","year":"2022","journal-title":"Neuroimage Clin"},{"key":"pone.0300298.ref030","doi-asserted-by":"crossref","first-page":"577653","DOI":"10.1016\/j.jneuroim.2021.577653","article-title":"Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review","volume":"358","author":"GY Gombolay","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"2","key":"pone.0300298.ref031","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/13524585211012349","article-title":"Leptomeningeal enhancement on post-contrast FLAIR images for early diagnosis of Susac syndrome","volume":"28","author":"G Bellanger","year":"2022","journal-title":"Mult Scler"},{"issue":"4","key":"pone.0300298.ref032","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3174\/ajnr.A5541","article-title":"Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis","volume":"39","author":"R Zivadinov","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"pone.0300298.ref033","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3174\/ajnr.A5273","article-title":"Pericortical Enhancement on Delayed Postgadolinium Fluid-Attenuated Inversion Recovery Images in Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease","volume":"38","author":"WM Freeze","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"pone.0300298.ref034","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/brain\/awab045","article-title":"Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition","volume":"144","author":"P Bhargava","year":"2021","journal-title":"Brain"},{"key":"pone.0300298.ref035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2019.01.013","article-title":"Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis","volume":"314","author":"S Pol","year":"2019","journal-title":"Exp Neurol"},{"issue":"6","key":"pone.0300298.ref036","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ana.25604","article-title":"Glymphatics Visualization after Focused Ultrasound-Induced Blood-Brain Barrier Opening in Humans","volume":"86","author":"Y Meng","year":"2019","journal-title":"Ann Neurol"},{"issue":"11","key":"pone.0300298.ref037","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3348\/kjr.2020.0042","article-title":"Neurofluid Dynamics and the Glymphatic System: A Neuroimaging Perspective","volume":"21","author":"T Taoka","year":"2020","journal-title":"Korean J Radiol"},{"issue":"3","key":"pone.0300298.ref038","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.25670","article-title":"Impairment of the Glymphatic Pathway and Putative Meningeal Lymphatic Vessels in the Aging Human","volume":"87","author":"Y Zhou","year":"2020","journal-title":"Ann Neurol"},{"issue":"1","key":"pone.0300298.ref039","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/13524585221122210","article-title":"Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients","volume":"29","author":"C Friedli","year":"2023","journal-title":"Mult Scler"},{"key":"pone.0300298.ref040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.msard.2019.02.013","article-title":"Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement","volume":"30","author":"P Bhargava","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"pone.0300298.ref041","doi-asserted-by":"crossref","first-page":"104094","DOI":"10.1016\/j.msard.2022.104094","article-title":"Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study","volume":"67","author":"R Zivadinov","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"pone.0300298.ref042","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8030344","article-title":"Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study","volume":"8","author":"R Zivadinov","year":"2019","journal-title":"J Clin Med"},{"issue":"11","key":"pone.0300298.ref043","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/RLI.0000000000000280","article-title":"Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion","volume":"51","author":"E. Lancelot","year":"2016","journal-title":"Invest Radiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T13:35:51Z","timestamp":1716989751000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300298"}},"subtitle":[],"editor":[{"given":"Arka","family":"Bhowmik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0300298","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}